COVID-19 and Cerebrovascular Diseases

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/3963

Full metadata record

DC Field	Value	Language
dc.contributor.author	Shavkat Karimov, Abdurasul Yulbarisov, Hojiakbar Alidjanov, Rustam Muminov, Viktoriya Tsay, Abduvali Jalilo	-
dc.date.accessioned	2022-10-13T06:40:06Z	-
dc.date.available	2022-10-13T06:40:06Z	-
dc.date.issued	2022-03-26	-
dc.identifier.isbn	978-86-80916-01-9	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3963	-
dc.description	We report the incidence of IS in COVID-19 patients to be 3.3%, with a high mortality rate. Elevated d-dimer, fibrinogen and the presence of antiphospholipid antibodies appear to be prominent in COVID-19 patients with concomitant IS, but further mechanistic studies are required to elucidate their role in pathogenesis.	en_US
dc.description.abstract	Ischemic stroke (IS) and thrombosis of carotid arteries are life-threatening complications of coronavirus disease 2019 (COVID-19) infection. Increasing reports suggest an association between COVID-19 and IS, although the underlying mechanism remains uncertain. Material and Methods. We analysed single-centre experience to characterise the clinical characteristics, neuroimaging findings, and outcomes of IS in COVID-19 patients from 1st December 2019 to February 2022.	en_US
dc.language.iso	en	en_US
dc.publisher	Serbia	en_US
dc.relation.ispartofseries	УДК;616.98:578.834	-
dc.title	COVID-19 and Cerebrovascular Diseases	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
1.pdf		116.36 kB	Adobe PDF	View/Open

DSpace JSPUI